RxDoctor Payments Data

Praveen Reddy Elmati, MD

Anesthesiology · Denville, NJNPI 1427544105

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $2,010 of the $3,120 with a category attached, or 64.4%. Medtronic accounts for 64.5% of it on its own, with 11 other manufacturers making up the rest. Reporting peaked in 2023 at $2,774 and has fallen 93.6% since, to $178 in 2024. Among anesthesiology clinicians in NJ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$3,120in general payments, 2019–2025

Across 50 payments — averaging $62.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$2K
  • SPR Therapeutics, Inc$297
  • Curonix LLC$264
  • Averitas Pharma Inc.$151
  • Boston Scientific$139
  • Nevro Corp.$63
  • plus $195 from 6 others

What the payments were for

  • Travel & lodging$1,10936%
  • Food & beverage$2,01064%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,120 in reported general payments places this provider in the 95th percentile of 1,430 anesthesiology providers in New Jersey.

See all anesthesiology providers in New Jersey

Medicare billing

Part B allowed, 2024
$160,273
Medicare patients
309
Services billed
1,695

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Oxycodone Hcl182$3,713
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen153$3,626
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen79$2,538
Gabapentin155$1,967
Tizanidine Hcl201$1,874
Morphine Sulfate ErMorphine Sulfate57$1,177
Naloxone Hcl17$963
Pregabalin42$651
Tramadol Hcl76$540
Cyclobenzaprine Hcl30$500
Morphine Sulfate16$414
Ibuprofen24$346
Duloxetine Hcl23$242
Baclofen16$240
Hydromorphone Hcl21$218

Paid to pharmacies, not to this prescriber.

Other anesthesiology in Denville

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →